A Review of Emerging Technologies for the Management of Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: High prevalence of diabetes mellitus (DM) along with the poor health outcomes and the escalated costs of treatment and care poses the need to focus on prevention, early detection and improved management of the disease. The aim of this paper is to present and discuss the latest accomplishments in sensors for glucose and lifestyle monitoring along with clinical decision support systems (CDSSs) facilitating self-disease management and supporting healthcare professionals in decision making. METHODS: A critical literature review analysis is conducted focusing on advances in: 1) sensors for physiological and lifestyle monitoring, 2) models and molecular biomarkers for predicting the onset and assessing the progress of DM, and 3) modeling and control methods for regulating glucose levels. RESULTS: Glucose and lifestyle sensing technologies are continuously evolving with current research focusing on the development of noninvasive sensors for accurate glucose monitoring. A wide range of modeling, classification, clustering, and control approaches have been deployed for the development of the CDSS for diabetes management. Sophisticated multiscale, multilevel modeling frameworks taking into account information from behavioral down to molecular level are necessary to reveal correlations and patterns indicating the onset and evolution of DM. CONCLUSION: Integration of data originating from sensor-based systems and electronic health records combined with smart data analytics methods and powerful user centered approaches enable the shift toward preventive, predictive, personalized, and participatory diabetes care. SIGNIFICANCE: The potential of sensing and predictive modeling approaches toward improving diabetes management is highlighted and related challenges are identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Learning Deep Architectures for AI
Bengio, Y. (2009) · Foundations and Trends® in Machine Learning · doi:10.1561/2200000006 · Cited by 9,239
A General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684 · cited 1×
“weighted correlation network builds upon the pairwise correlation between features determining the significance of each link [136].”
BackgroundIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459 · cited 6×
“CVD and diabetic retinopathy constitute the most commonly target complications.”
BackgroundMethodInfluentialNonlinear model predictive control of glucose concentration in subjects with type 1 diabetes
Hovorka, R., Canonico, V., Chassin, L. J., Haueter, U., Massi-Benedetti, M., Federici, M. O., Pieber, T. R., Schaller, H. C., Schaupp, L., Vering, T., et al. (2004) · Physiological Measurement · doi:10.1088/0967-3334/25/4/010 · Cited by 1,274
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084
DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Mahajan, A., Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium, Mexican American Type 2 Diabetes (MAT2D) Consortium, Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) Consortium, Go, M. J., Zhang, W., Below, J. E., Gaulton, K. J., et al. (2014) · Nature Genetics · doi:10.1038/ng.2897 · Cited by 1,034
Floegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., et al. (2013) · Diabetes · doi:10.2337/db12-0495 · Cited by 988 · cited 2×
“biological processes affected by gene, protein, and metabolite factors [5], [112], [113].”
BackgroundGenomics, type 2 diabetes, and obesity
McCarthy, M. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906948 · Cited by 938
In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Kovatchev, B. P., Breton, M., Dalla Man, C., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300106 · Cited by 760
Novel biomarkers for pre-diabetes identified by metabolomics
Wang‐Sattler, R., Yu, Z., Herder, C., Messias, A. C., Floegel, A., He, Y., Heim, K., Campillos, M., Holzapfel, C., Thorand, B., et al. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.43 · Cited by 701
Epigenetics: a molecular link between environmental factors and type 2 diabetes
Ling, C., & Groop, L. (2009) · Diabetes · doi:10.2337/db09-1003 · Cited by 617 · cited 1×
“to T2DM [119], [120].”
Clarke, P. M., Gray, A. M., Briggs, A., Farmer, A. J., Fenn, P., Stevens, R. J., Matthews, D. R., Stratton, I. M., Holman, R. R., & on behalf of the UK Prospective Diabetes Study (UKPDS) Group (2004) · Diabetologia · doi:10.1007/s00125-004-1527-z · Cited by 615 · cited 1×
“Weibull proportional hazard regression model UKPDS 5102 T2DM patients Death, MI, stroke, heart failure, amputation, renal failure, diabetic eye disease [65]”
MethodGlucose sensors: a review of current and emerging technology
Oliver, N. S., Toumazou, C., Cass, A. E. G., & Johnston, D. G. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02642.x · Cited by 584 · cited 1×
“, reverse iontophoresis and sonophoresis) [22].”
Diabetes: Models, Signals, and Control
Cobelli, C., Dalla Man, C., Sparacino, G., Magni, L., De Nicolao, G., & Kovatchev, B. P. (2009) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2009.2036073 · Cited by 511
Collins, G. S., Mallett, S., Omar, O., & Yu, L.-M. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-103 · Cited by 484 · cited 3×
“The IIAS has been in silico evaluated using the UVa T1DM simulator [100] and its performance has been compared against both the adaptive basal therapy presented in [41] and the artificial pancreatic b-cell,”
BackgroundMethodIntelligible Support Vector Machines for Diagnosis of Diabetes Mellitus
Barakat, N., Bradley, A. P., & Barakat, M. N. H. (2010) · IEEE Transactions on Information Technology in Biomedicine · doi:10.1109/titb.2009.2039485 · Cited by 367 · cited 1×
“00 [45]”
Abbasi, A., Peelen, L. M., Corpeleijn, E., van der Schouw, Y. T., Stolk, R. P., Spijkerman, A. M. W., van der A, D. L., Moons, K. G. M., Navis, G., Bakker, S. J. L., et al. (2012) · BMJ · doi:10.1136/bmj.e5900 · Cited by 321
Model Predictive Control of Type 1 Diabetes: An in Silico Trial
Magni, L., Raimondo, D. M., Bossi, L., Dalla Man, C., De Nicolao, G., Kovatchev, B., & Cobelli, C. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100603 · Cited by 317
Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors
Kovatchev, B. P., Gonder-Frederick, L. A., Cox, D. J., & Clarke, W. L. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1922 · Cited by 312
GIM, Simulation Software of Meal Glucose–Insulin Model
Dalla Man, C., Raimondo, D. M., Rizza, R. A., & Cobelli, C. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100303 · Cited by 253
Hovorka, R., Kumareswaran, K., Harris, J., Allen, J. M., Elleri, D., Xing, D., Kollman, C., Nodale, M., Murphy, H. R., Dunger, D. B., et al. (2011) · BMJ · doi:10.1136/bmj.d1855 · Cited by 244 · cited 2×
“[84], [85] or model predictive control (MPC) [86]–[96].”
BackgroundNovel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes
Castle, J. R., Engle, J. M., Youssef, J. E., Massoud, R. G., Yuen, K. C. J., Kagan, R., & Ward, W. K. (2010) · Diabetes Care · doi:10.2337/dc09-2254 · Cited by 232
Analysis of Chewing Sounds for Dietary Monitoring
Amft, O., Stäger, M., Lukowicz, P., & Tröster, G. (2005) · Lecture Notes in Computer Science · doi:10.1007/11551201_4 · Cited by 216
Tools for Predicting the Risk of Type 2 Diabetes in Daily Practice
Schwarz, P., Li, J., Lindstrom, J., & Tuomilehto, J. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0028-1087203 · Cited by 213
Epigenetic mechanisms in the development of type 2 diabetes
Pinney, S. E., & Simmons, R. A. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.10.002 · Cited by 205 · cited 1×
“to T2DM [119], [120].”
Kovatchev, B., Cobelli, C., Renard, E., Anderson, S., Breton, M., Patek, S., Clarke, W., Bruttomesso, D., Maran, A., Costa, S., et al. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400611 · Cited by 200
Clarke, W. L., Anderson, S., Breton, M., Patek, S., Kashmer, L., & Kovatchev, B. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300506 · Cited by 185
Cited by
Woldaregay, A. Z., Årsand, E., Walderhaug, S., Albers, D., Mamykina, L., Botsis, T., & Hartvigsen, G. (2019) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2019.07.007 · Cited by 358
A review of personalized blood glucose prediction strategies for T1DM patients
Oviedo, S., Vehí, J., Calm, R., & Armengol, J. (2017) · International Journal for Numerical Methods in Biomedical Engineering · doi:10.1002/cnm.2833 · Cited by 279
Jacobs, P. G., Herrero, P., Facchinetti, A., Vehi, J., Kovatchev, B., Breton, M. D., Cinar, A., Nikita, K. S., Doyle, F. J., Bondia, J., et al. (2024) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2023.3331297 · Cited by 113
Self-citationAn Ontology-Based Interpretable Fuzzy Decision Support System for Diabetes Diagnosis
El-Sappagh, S., Alonso, J. M., Ali, F., Ali, A., Jang, J.-H., & Kwak, K.-S. (2018) · IEEE Access · doi:10.1109/access.2018.2852004 · Cited by 79
“The undiagnosed cases of DM are as high as 179 million [1].”
BackgroundLimits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials
Schrangl, P., Reiterer, F., Heinemann, L., Freckmann, G., & Del Re, L. (2018) · Biosensors · doi:10.3390/bios8020050 · Cited by 46
Metadata
- Authors
- Zarkogianni, K., Litsa, E., Mitsis, K., Wu, P.-Y., Kaddi, C. D., Cheng, C.-W., Wang, M. D., & Nikita, K. S.
- Venue
- IEEE Transactions on Biomedical Engineering
- Published
- 2015-12
- Volume
- 62
- Issue
- 12
- Pages
- 2735-2749
- ISSN
- 0018-9294 (ISSN-L)
- 1558-2531
- OpenAlex
- W2147972594
- Cited by
- 112
- References
- 29
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.